Haemonetics Corp (HAE)
85.43
+0.51
(+0.60%)
USD |
NYSE |
Nov 21, 16:00
85.46
+0.04
(+0.04%)
Pre-Market: 20:00
Haemonetics Enterprise Value: 5.216B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 5.216B |
| November 20, 2024 | 5.191B |
| November 19, 2024 | 5.186B |
| November 18, 2024 | 5.354B |
| November 15, 2024 | 5.407B |
| November 14, 2024 | 5.483B |
| November 13, 2024 | 5.535B |
| November 12, 2024 | 5.616B |
| November 11, 2024 | 5.516B |
| November 08, 2024 | 5.316B |
| November 07, 2024 | 5.272B |
| November 06, 2024 | 4.851B |
| November 05, 2024 | 4.691B |
| November 04, 2024 | 4.630B |
| November 01, 2024 | 4.527B |
| October 31, 2024 | 4.511B |
| October 30, 2024 | 4.554B |
| October 29, 2024 | 4.609B |
| October 28, 2024 | 4.741B |
| October 25, 2024 | 4.732B |
| October 24, 2024 | 4.745B |
| October 23, 2024 | 4.618B |
| October 22, 2024 | 4.678B |
| October 21, 2024 | 4.698B |
| October 18, 2024 | 4.762B |
| Date | Value |
|---|---|
| October 17, 2024 | 4.752B |
| October 16, 2024 | 4.733B |
| October 15, 2024 | 4.714B |
| October 14, 2024 | 4.719B |
| October 11, 2024 | 4.703B |
| October 10, 2024 | 4.677B |
| October 09, 2024 | 4.760B |
| October 08, 2024 | 4.789B |
| October 07, 2024 | 4.815B |
| October 04, 2024 | 4.850B |
| October 03, 2024 | 4.859B |
| October 02, 2024 | 4.921B |
| October 01, 2024 | 4.906B |
| September 30, 2024 | 4.975B |
| September 27, 2024 | 4.963B |
| September 26, 2024 | 4.797B |
| September 25, 2024 | 4.722B |
| September 24, 2024 | 4.743B |
| September 23, 2024 | 4.788B |
| September 20, 2024 | 4.709B |
| September 19, 2024 | 4.722B |
| September 18, 2024 | 4.749B |
| September 17, 2024 | 4.796B |
| September 16, 2024 | 4.806B |
| September 13, 2024 | 4.773B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.777B
Minimum
Jan 27 2022
7.209B
Maximum
Feb 08 2021
4.729B
Average
4.735B
Median
Jul 05 2023
Enterprise Value Benchmarks
| Boston Scientific Corp | 143.48B |
| Baxter International Inc | 28.43B |
| Globus Medical Inc | 11.30B |
| ResMed Inc | 36.01B |
| Integra Lifesciences Holdings Corp | 3.304B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 33.83M |
| Revenue (Quarterly) | 345.51M |
| Total Expenses (Quarterly) | 293.81M |
| EPS Diluted (Quarterly) | 0.66 |
| Gross Profit Margin (Quarterly) | 54.25% |
| Profit Margin (Quarterly) | 9.79% |
| Earnings Yield | 2.82% |
| Operating Earnings Yield | 3.77% |
| Normalized Earnings Yield | 2.781 |